{"version":"1.0","type":"link","title":"Is it feasible for CDKs inhibitors to herald a new era in tackling the low sensitivity and drug resistance associated with PARP inhibitors?","author_name":"Wang YL 외","author_url":"https://prs-insight.online/author/Wang%20YL","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75514","thumbnail_width":1200,"thumbnail_height":630}